AI & Biosecurity: White House Policy on Risky Research

Experts warn that artificial intelligence could lower barriers to malicious use and risky scientific mistakes in biological research. Life sciences, pharmaceutical, and biotechnology firms are using AI to speed up discoveries and medical innovations. However, AI also poses potential biological threats when used by malicious actors or through benign mishaps. The White House recently issued a policy paper addressing potential "high-risk" life sciences research. This includes dangerous "gain-of-function" research funded by the U.S. government. Such research could involve biological agents with a substantial risk of negative societal consequences, impacting public health, biosecurity, or national security. The new policy prohibits federal support for dangerous gain-of-function research, establishes independent review for high-risk life sciences research, and restricts federal funding to institutions lacking appropriate biosafety and biosecurity standards. The policy paper acknowledges AI-related risks and plans for an interagency group to monitor advancements at the intersection of biological sciences and AI. Experts are most concerned about novel bioweapons or dangerous unintended accidents. AI tools could make it easier to design biological agents that evade existing defenses and allow less-skilled users to perform sophisticated biological research, creating dangerous substances. However, significant scientific and laboratory barriers still exist between AI-generated instructions and the creation of novel pathogens. This matters because the same AI advancements that benefit legitimate researchers can also be exploited by malicious actors, posing a complex challenge for global security.